However, studies have found that the expression of nicotinamide nucleotide adenylyltransferase (NMNAT) is decreased in the brain tissue of PD patients, and NMNAT is a key enzyme involved in NAD + biosynthesis (Challa et al., 2021; Schöndorf et al., 2018). The gene discussed is NMNAT1; the disease is Parkinson disease.